You are here

Vynfinit

Endocyte, Merck Cancer Drug Scores Twice

investors.com

Sat, 03/22/14 - 11:36 am

EMA committee backs conditional approval of Merck & Co., Endocyte's Vynfinit for ovarian cancer

First Word Pharma

Fri, 03/21/14 - 08:50 am